Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;14(1):12-7.
doi: 10.1016/j.aju.2015.11.004. Epub 2015 Dec 31.

Silodosin vs tamsulosin in the management of distal ureteric stones: A prospective randomised study

Affiliations

Silodosin vs tamsulosin in the management of distal ureteric stones: A prospective randomised study

Hazem Elgalaly et al. Arab J Urol. 2016 Mar.

Abstract

Objectives: To compare the efficacy of silodosin (8 mg) vs tamsulosin (0.4 mg), as a medical expulsive therapy, in the management of distal ureteric stones (DUS) in terms of stone clearance rate and stone expulsion time.

Patients and methods: A prospective randomised study was conducted on 115 patients, aged 21-55 years, who had unilateral DUS of ⩽10 mm. Patients were divided into two groups. Group 1 received silodosin (8 mg) and Group 2 received tamsulosin (0.4 mg) daily for 1 month. The patients were followed-up by ultrasonography, plain abdominal radiograph of the kidneys, ureters and bladder, and computed tomography (in some cases).

Results: There was a significantly higher stone clearance rate of 83% in Group 1 vs 57% in Group 2 (P = 0.007). Group 1 also showed a significant advantage for stone expulsion time and analgesic use. Four patients, two in each group, discontinued the treatment in first few days due to side-effects (orthostatic hypotension). No severe complications were recorded during the treatment period. Retrograde ejaculation was recorded in nine and three patients in Groups 1 and 2, respectively.

Conclusion: Our data show that silodosin is more effective than tamsulosin in the management of DUS for stone clearance rates and stone expulsion times. A multicentre study on larger scale is needed to confirm the efficacy and safety of silodosin.

Keywords: DUS, distal ureteric stones; Distal; KUB, plain abdominal radiograph of the kidneys, ureters and bladder; MET, medical expulsive therapy; SWL, shockwave lithotripsy; Silodosin; Stone; Tamsulosin; Ureteric.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of the study design. ttt, treat-to-target.
Figure 2
Figure 2
Kaplan–Meier function curve.

References

    1. Curhan G.C. Epidemiology of stone disease. Urol Clin North Am. 2007;34:287–293. - PMC - PubMed
    1. Erturhan S., Erbagci A., Yagci F., Celik M., Solakhan M., Sarica K. Comparative evaluation of efficacy of use of tamsulosin and/or tolterodine for medical treatment of distal ureteral stones. Urology. 2007;69:633–636. - PubMed
    1. Segura J.W., Preminger G.M., Assimos D.G., Dretler S.P., Kahn R.I., Lingeman J.E. Ureteral stones clinical guidelines panel summary report on the management of ureteral calculi. The American Urological Association. J Urol. 1997;158:1915–1921. - PubMed
    1. Cervenakov I., Fillo J., Mardiak J., Kopecny M., Smirala J., Lepies P. Speedy elimination of ureterolithiasis in lower part of ureters with the alpha1-blocker-Tamsulosin. Int Urol Nephrol. 2002;34:25–29. - PubMed
    1. Tzortzis V., Mamoulakis C., Rioja J., Gravas S., Michel M.C., de la Rosette J.J. Medical expulsive therapy for distal ureteral stones. Drugs. 2009;69:677–692. - PubMed

LinkOut - more resources